Dear members, partners and friends of ESBB,

We highly appreciate you taking the time to answer this survey which will take about 10 minutes for 48 questions. This survey should help us all to understand and learn about shortcomings, needs and strategies for the biobank community in such an unprecedented challenging and difficult time due to the COVID-19 pandemic. Biobanks can play a significant role in providing samples and data for COVID-19 associated research in order to overcome this devastating pandemic. Thus, guaranteeing our biobanks’ functionality during this and potentially future crises is fundamental.

This survey is fully anonymous. However, in case you are interested in getting engaged in our ESBB COVID-19 Task Force, please e-mail our ESBB office at ESBB@mci-group.com. The results of this survey will be shown on our website (www.esbb.org) and may lead to a scientific publication or white paper. Your feedback to the survey and specifically your free text reply at the end of the survey may direct us to develop tools and support or bring clarity to meet your particular COVID-19 needs.
Please make sure to answer this Survey by April 30th!

Question Title

* 1. Are you a (please tick all that apply)

Question Title

* 2. If you are a clinician, nurse or technician, are you working in

Question Title

* 3. In this survey, are you representing a/an (please tick all that apply)

Question Title

* 4. If you are working in a biobank, how is your biobank best described? (please tick all that apply)

Question Title

* 5. How long have you been working in the respective biobank or other field?

Question Title

* 6. In which geographical region according to the United Nations is your institution located?

Question Title

* 7. What is your highest degree:

Question Title

* 8. How old are you?

Question Title

* 9. Are you a member of

Question Title

* 10. Now we’d like to hear about your experiences during the COVID-19 crisis.

Was your working place operational all the time since COVID-19 crisis started?

Question Title

* 11. In case your working place was shut down due to the COVID-19 crisis, for how long?

Question Title

* 12. Was your work affected by other restrictions than shut down?

Question Title

* 13. Now we’d like to hear about COVID-19 effects on biobanking.

Is your biobank by law/regulations allowed to collect/store COVID-19 samples?

Question Title

* 14. Does your biobank collect COVID-19 samples?

Question Title

* 15. If your biobank is involved in COVID-19 collections, to what extend (please tick all that apply)

Question Title

* 16. Why do you think your biobank is involved in COVID-19 sampling? (please tick all that apply)

Question Title

* 17. What are the difficulties you encountered? (please tick all that apply)

Question Title

* 18. Does your biobank actually collect COVID samples (please tick all that apply)

Question Title

* 19. Does your biobank plan to collect COVID samples (please tick all that apply)

Question Title

* 20. How is your interaction with the local ethics committee to act on COVID-19 ethics approvals and/or guidance best described:

Question Title

* 21. How fast did your local ethics board react to requests/ethical applications?

Question Title

* 22. Does your biobank collect (please tick all that apply)

  Yes Plan to do so No
a) Neonate COVID-19 positive samples
b) Paediatric COVID-19 positive samples
c) COVID-19 positive samples from oncology patients
d) COVID-19 positive samples from cardiology patients
e) COVID-19 positive samples from diabetic patients
f) COVID-19 positive samples from immune disease patients

Question Title

* 23. If you actually collect COVID-19 samples, what type? (please complete all that apply)

Question Title

* 24. If you plan to collect COVID-19 samples, what type? (please complete all that apply)

Question Title

* 25. Do you perform longitudinal sampling for COVID-19 patients?

Question Title

* 26. If yes, how often do you sample subsequently from the same patient?

Question Title

* 27. Is your sampling strategy for COVID-19 harmonized with other biobanks?

Question Title

* 28. Would your COVID-19 samples be available for external research projects?

Question Title

* 29. If yes, would your COVID-19 samples also be available for industry projects?

Question Title

* 30. Are you collecting clinical data parameters with the samples?

Question Title

* 31. Do you submit COVID-19 data to national registries?

Question Title

* 32. Do you submit COVID-19 data to international registries?

Question Title

* 33. Do you submit COVID-19 data to the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) register?

Question Title

* 34. Do you receive any additional funding specific for COVID-19 biobanking? (please tick all that apply)

Question Title

* 35. We are further interested to understand more about the security measures you take for sampling, processing, and storage.

Do you need a certain safety level to store your samples due to regulations?

Question Title

* 36. Do you need a certain safety level for sample processing (e.g., extract PBMCs or DNA from sputum) due to regulations?

Question Title

* 37. Does your biobank need to collaborate with other institutes for sample processing due to regulations, e.g., as your facility does not have the required safety level?

Question Title

* 38. At what temperatures do you store your samples? (please tick all that apply)

Question Title

* 39. Now we want to hear about your supplies during the COVID-19 crisis.

Did you, and do you still, have sufficient self-protection available?

  Yes No
a) Surgical mask?
b) FFP2 mask?
c) FFP3 mask?
d) Protective gear?
e) Gloves?
f) Disinfectant?

Question Title

* 40. Did you experience any shortcomings for self-protection gear?

Question Title

* 41. Did you experience any shortcomings on consumables, e.g., tubes, kits, reagents for sample processing/storage?

Question Title

* 42. Now we’d like to understand what you would expect from our ESBB COVID Task Force.

Would you like to be part of our ESBB COVID-19 Task Force:

Question Title

* 43. What would you expect from our ESBB COVID-19 Task Force: (please tick all that apply)

Question Title

* 44. How often would you like to have a COVID-19 Webinar?

Question Title

* 45. What would be your preferred day of the week for such a webinar? (please tick all that apply)

Question Title

* 46. What would be your preferred time of the day for such a webinar? (please tick all that apply)

Question Title

* 47. How long should such a webinar ideally last:

Question Title

* 48. Please use the space below to suggest or comment on anything we might have missed to ask and/or what you deem being crucial to support the biobank community, clinicians, nurses, and patients overall.

0 of 48 answered
 

T